PHOCCS project
fast detection technology
unique technology
disruptive technology fundamental
Photon Cross Correlation Spectroscopy
large molecular diagnostics market
strategic applications of molecular diagnostics
ultra-sensitive detection of DNA biomolecules
molecular biomarkers indicative of bacterial infection
DNA sensing
year of sepsis
key advantages
commercial success
severe bloodstream infection
targeted antibiotics therapy
industrial market needs
breakthrough platform
novel concepts
dynamic light
limited time
noble metal nanoparticles
transferability
nucleic acid amplification processes
risk of antimicrobial resistance
pre-demonstration stage
Europe
commercialization
patented intellectual property
people
development
hospitalization costs
limitations of fluorescence labelling
licensing opportunities